KGX101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for KGX101, covering 2025-02-07 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients [Phase 1]